Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes

AUTOR(ES)

Fernández, Ana M.

FONTE

Cold Spring Harbor Laboratory Press

RESUMO

Peripheral insulin resistance and impaired insulin action are the primary characteristics of type 2 diabetes. The first observable defect in this major disorder occurs in muscle, where glucose disposal in response to insulin is impaired. We have developed a transgenic mouse with a dominant-negative insulin-like growth factor-I receptor (KR–IGF-IR) specifically targeted to the skeletal muscle. Expression of KR–IGF-IR resulted in the formation of hybrid receptors between the mutant and the endogenous IGF-I and insulin receptors, thereby abrogating the normal function of these receptors and leading to insulin resistance. Pancreatic β-cell dysfunction developed at a relative early age, resulting in diabetes. These mice provide an excellent model to study the molecular mechanisms underlying the development of human type 2 diabetes.

Documentos Relacionados

• Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle
• Placental Structure in Type 1 Diabetes: Relation to Fetal Insulin, Leptin, and IGF-I
• Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts.
• β cell expression of IGF-I leads to recovery from type 1 diabetes
• Granulosa cell-derived insulin-like growth factor (IGF) binding proteins are inhibitory to IGF-I hormonal action. Evidence derived from the use of a truncated IGF-I analogue.